HomeAI · summaries
Storia in 19 fonti
Cáncer de páncreas: cómo actúa el fármaco experimental que duplicó la supervivencia en uno de los tumores más mortales
Los resultados del ensayo clínico con daraxonrasib se presentaron ayer en la reunión anual de la Sociedad Estadounidense de Oncología Clínica en Chicago. “Representa un cambio de paradigma”, dijeron los investigadores
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
- ·
independent.co.uk
Daily pill almost doubles survival time for pancreatic cancer patients in new trial
Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease
- ·
theguardian.com
Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer
- ·
elpais.com
Vuelta de tuerca en el tumor más letal: una terapia dirigida logra duplicar la supervivencia en el cáncer de páncreas
Un fármaco innovador consigue supervivencias de hasta 13 meses, el doble que con la quimioterapia convencional. Es una mejora sin precedentes en décadas
- ·
Experimental pill promises new hope for deadly pancreatic cancer
New research shows a novel pill is helping people with advanced pancreatic cancer live longer
- ·
tg24.sky.it
Tumore al pancreas, studio: un nuovo farmaco allunga la sopravvivenza
Leggi su Sky TG24 l'articolo Tumore al pancreas, un nuovo farmaco sperimentale aumenta la sopravvivenza. Lo studio
- ·
elnuevodia.com
“Es un gran paso”: píldora experimental promete nueva esperanza contra el mortal cáncer de páncreas
¿Cómo funciona? Esto es lo que dice un estudio
- ·
cbsnews.com
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
- ·
fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
- ·
20minutos.es
Un ensayo identifica un tratamiento que duplica la supervivencia de pacientes con cáncer de páncreas avanzado
Los pacientes tratados alcanzan una supervivencia media de 13,2 meses frente a los 6,7 de la quimioterapia convencional. En la investigación ha participado el Hospital Clínic de…
- ·
calabria7.news
Tumore al pancreas, svolta dalla ricerca: il farmaco daraxonrasib raddoppia la sopravvivenza (Calabria 7)
Un nuovo studio clinico sta attirando grande attenzione nella comunità scientifica internazionale per i risultati ottenuti nel trattamento del tumore al
- ·
sciencedaily.com
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most…
- ·
fanpage.it
Tumore al pancreas, pillola daraxonrasib raddoppia la sopravvivenza: “È una svolta, ho pianto quando ho visto i risultati”
Il farmaco daraxonrasib contro il cancro al pancreas ha dimostrato risultati rivoluzionari in un nuovo studio
- ·
newsbytesapp.com
This drug can double survival time for pancreatic cancer patients
A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.
- ·
g4media.ro
STUDIU: Un nou medicament dublează perioada de supraviețuire pentru pacienții diagnosticați cu cancer pancreatic
S-a descoperit că o pastilă poate aproape dubla perioada de supraviețuire pentru pacienții cu cancer pancreatic avansat, experții descriind studiul clinic ca fiind revoluționar.
- ·
virgilio.it
Tumore al pancreas, la nuova cura con compresse di daraxonrasib dà speranza: come funziona la molecola
La molecola daraxonrasib raddoppia la sopravvivenza contro il tumore al pancreas: i dati promettenti dello studio clinico presentati all'Asco
- ·
infobae.com
Cáncer de páncreas: cómo actúa el fármaco experimental que duplicó la supervivencia en uno de los tumores más mortales
Los resultados del ensayo clínico con daraxonrasib se presentaron ayer en la reunión anual de la Sociedad Estadounidense de Oncología Clínica en Chicago. “Representa un cambio de…
- ·
eu.usatoday.com
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who can get it.
- ·
newscientist.com
'Transformative' pancreatic cancer drug doubles survival time
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
- ·
cbc.ca
'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows | CBC News
An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.